About Molbio Diagnostics
Molbio Diagnostics is a company based in India founded in 2000 by Chandrasekhar Nair and Sriram Natarajan. Molbio Diagnostics has raised $123.98 million across 4 funding rounds from investors including Motilal Oswal, Temasek and ACT Grants. The company has 616 employees as of April 20, 2024. Molbio Diagnostics has completed 1 acquisition, including Prognosys Medical Systems. Molbio Diagnostics offers products and services including Truenat and Truenat Assays. Molbio Diagnostics operates in a competitive market with competitors including DermTech, Inflammatix, Karius, MeMed and Visby Medical, among others.
- Headquarter Salcete, India
- Employees 616 as on 20 Apr, 2024
- Founders Chandrasekhar Nair, Sriram Natarajan
- Stage Unicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Molbio Diagnostics Limited
- Date of Incorporation 20 Oct, 2000
- Jurisdiction Salcete, Goa, India
-
Annual Revenue
$40.57 M (USD)-56.83as on Mar 31, 2023
-
Net Profit
-$414.21 K (USD)-101.6as on Mar 31, 2023
-
EBITDA
$5.19 M (USD)-88.36as on Mar 31, 2023
-
Total Equity Funding
$123.98 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Motilal Oswal
& 4 more
-
Employee Count
616
as on Apr 20, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molbio Diagnostics
Molbio Diagnostics offers a comprehensive portfolio of products and services, including Truenat and Truenat Assays.
Portable real-time PCR device for detecting multiple infectious diseases
Assays for use with Truenat platform to identify pathogens
People of Molbio Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Molbio Diagnostics
Molbio Diagnostics has successfully raised a total of $123.98M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Molbio Diagnostics
Molbio Diagnostics has secured backing from 5 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Motilal Oswal, Temasek and ACT Grants.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed capital grants are provided to incubate and accelerate innovations.
|
Locked | Locked | Locked | |
|
An investment platform is provided for diverse sectors and geographies.
|
Locked | Locked | Locked | |
|
Motilal Oswal Alternates is engaged in alternative investment management.
|
Locked | Locked | Locked |
Investor details for Molbio Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Molbio Diagnostics
Molbio Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Prognosys Medical Systems.
Investment portfolio details for Molbio Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
High-end medical devices for radiology and imaging are manufactured.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for Molbio Diagnostics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Molbio Diagnostics
Detailed financials for Molbio Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Molbio Diagnostics Comparisons
Peer comparison for Molbio Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Molbio Diagnostics
Molbio Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, Inflammatix, Karius, MeMed and Visby Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
Detailed competitors of Molbio Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Molbio Diagnostics
Complete news archive for Molbio Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molbio Diagnostics
Molbio Diagnostics was founded in 2000 and raised its 1st funding round 20 years after it was founded.
Molbio Diagnostics is headquartered in India. It is registered at Goa, India.
Sriram Natarajan is the current CEO of Molbio Diagnostics. They have also founded this company.
Molbio Diagnostics is a funded company, having raised a total of $123.98M across 4 funding rounds to date.
As of Apr 20, 2024, the latest employee count at Molbio Diagnostics is 616.
Annual revenue of Molbio Diagnostics is $40.57M as on Mar 31, 2023.
Developer of point-of-care molecular diagnostic platform for infectious disease detection. The solution includes Trueprep a fully automatic universal cartridge-based sample prep device, Prolab Atlus portable x-ray system, Thermalytix AI-based thermal scanning device, and Truelab, a real-time, quantitative micro-PCR analyzer that targets diseases like rifampicin resistance, COVID19, influenza, dengue, hepatitis, HPV, malaria, and others.
Molbio Diagnostics's top competitors include Visby Medical, Inflammatix and DermTech.
Molbio Diagnostics offers Truenat and Truenat Assays.
Molbio Diagnostics has made 1 acquisition, including Prognosys Medical Systems.
Molbio Diagnostics has 5 investors. Key investors include Motilal Oswal, Temasek, ACT Grants, Motilal Oswal Alternates, and Shankar Gopalakrishnan.
The valuation of Molbio Diagnostics is $1.6B as of Sep 2022.